|
受注:045-509-1970 |
技術サポート:tech@selleck.co.jp 平日9:00〜18:00 1営業日以内にご連絡を差し上げます |
|
Synonyms | NSC105823, AICA Riboside | Storage (From the date of receipt) |
3 years -20°C powder 1 years -80°C in solvent |
|||
| 化学式 | C9H14N4O5 |
||||||
| 分子量 | 258.23 | CAS No. | 2627-69-2 | ||||
| Solubility (25°C)* | 体外 | DMSO | 52 mg/mL (201.37 mM) | ||||
| Water | 52 mg/mL (201.37 mM) | ||||||
| Ethanol | Insoluble | ||||||
| 体内 (毎回新しく調製した物を用意してください) |
|
||||||
|
* <1 mg/ml means slightly soluble or insoluble. * Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
|||||||
| 製品説明 | AMPK活性化剤であるAICAR(Acadesine、NSC105823、AICA Riboside)は、ZMPを蓄積させ、AMPのAMPKおよびAMPKキナーゼに対する刺激効果を模倣します。AICAR(Acadesine)はmitophagyを誘導します。フェーズ3。 |
|---|---|
| in vitro | Acadesine (500 μM) increases the ZMP content in extracts of isolated hepatocytes after up to 30-40 min treatment, then remains fairly constant at approximately 4 nmol/g. This compound causes a transient 12-fold activation of AMPK at 15 min in rat hepatocytes and 2-3 fold activation of AMPK in adipocytes, without affecting levels of ATP, ADP or AMP. It also causes a dramatic inhibition of both fatty acid and sterol synthesis in rat hepatocytes, as well as a dramatic inactivation of HMG-CoA reductase. AICAR induces apoptosis of B-CLL cells in a dose-dependent manner with EC50 of 380 μM. At 0.5 mM, it decreases cell viability of B-CLL cells from 20 representative patients from 68% to 26%, and induces caspase activation and cytochrome c release from mitochondria. Uptake and phosphorylation of the compound are required to induce apoptosis and activate AMPK in B-CLL cells. While concentrations of 2-4 mM only slightly affect the viability of T cells from B-CLL patients, 0.5 mM remarkedly reduces viability of B cells but not T cells. It triggers loss of cell metabolism in K562, LAMA-84 and JURL-MK1 and is also effective in killing resistant K562 cells and Ba/F3 cells carrying the T315I-BCR-ABL mutation. The effect of AICAR is abrogated by GF109203X and Ro-32-0432, both inhibitor of classical and new PKCs and accordingly, it triggers relocation and activation of several PKC isoforms in K562 cells. The compound dose-dependently inhibits K562 colony formation at day 10, the growth inhibitory effect is already detected at 0.25 mM and is maximal at 2.5 mM. AICAR causes a concentration-related reduction in CD18 expression on LPS-stimulated neutrophils in vitro. It significantly (1 mM) inhibits N-formyl-methionyl-leucyl-phenylalanine-induced granulocyte CD11b up-regulation by a mean of 61% in blood. |
| in vivo | Acadesine (50 mg/kg) significantly reduces tumor formation in a mouse xenograft model of K562 cells. At 10 mg/kg, this compound results in higher fluid required to stabilize hemodynamics in pigs and inhibits LPS-induced protein permeability of pulmonary capillaries, peak inspiratory pressures on constant tidal volume and dead space ventilation. |
| 特徴 | A potential first-in-class ARA. |
| 細胞アッセイ | 細胞株 | K562 cell lines |
|---|---|---|
| 濃度 | 2.5 mM | |
| 反応時間 | 10 days | |
| 実験の流れ | AICAR (Acadesine) is added to K562 cell lines or primary cells (103 CD34+ cells/mL) growing in semisolid methyl cellulose medium. MethoCult H4100 or H4236 are used for cell lines and primary CD34+ cells respectively. Colonies are detected after 10 days of culture by adding 1 mg/mL of the MTT reagent and are scored by Image J quantification software. |
|
| 動物実験 | 動物モデル | mouse xenograft model of K562 cells |
| 投薬量 | 50 mg/kg | |
| 投与方法 | Injected intraperitoneally |
|

, , British Journal of Pharmacology, 2015, 172(13):3284–3301.

, , J Appl Toxicol, 2017, 37(10):1219-1224

Data from [Data independently produced by , , J Clin Invest, 2019, 129(1):252-267]
| CD137L promotes immune surveillance in melanoma via HLTF regulation [ Nat Commun, 2025, 16(1):8478] | PubMed: 41006211 |
| Calcium dysregulation disrupts mitochondrial homeostasis by interfering AMPK/Drp1 pathway to aggravate plaque progression and instability [ Theranostics, 2025, 15(15):7567-7583] | PubMed: 40756371 |
| Hypothalamic Astrocytes Exhibit Glycolytic Features Making Them Prone for Glucose Sensing [ Glia, 2025, 73(11):2253-2272] | PubMed: 40708167 |
| Knockdown of POLG Mimics the Neuronal Pathology of Polymerase-γ Spectrum Disorders in Human Neurons [ Cells, 2025, 14(7)480] | PubMed: 40214434 |
| Suppression of Fibroblast Growth Factor 23 in UMR106 Osteoblast-Like Cells and MC3T3-E1 Cells by Adipokine Chemerin [ Cell Biochem Funct, 2025, 43(2):e70051] | PubMed: 39887469 |
| Nuclear PD-L1 compartmentalization suppresses tumorigenesis and overcomes immunocheckpoint therapy resistance in mice via histone macroH2A1 [ J Clin Invest, 2024, 134(22)e181314] | PubMed: 39545415 |
| PRMT5 mediated FUBP1 methylation accelerates prostate cancer progression [ J Clin Invest, 2024, e175023] | PubMed: 39146021 |
| Brain Short-Chain Fatty Acids Induce ACSS2 to Ameliorate Depressive-Like Behavior via PPARγ-TPH2 Axis [ Research (Wash D C), 2024, 7:0400] | PubMed: 38939042 |
| Aerobic exercise suppresses CCN2 secretion from senescent muscle stem cells and boosts muscle regeneration in aged mice [ J Cachexia Sarcopenia Muscle, 2024, 15(5):1733-1749] | PubMed: 38925632 |
| Metabolic regulation of misfolded protein import into mitochondria [ Elife, 2024, 12RP87518] | PubMed: 38900507 |
長期の保管のために-20°Cの下で製品を保ってください。
人間や獣医の診断であるか治療的な使用のためにでない。
各々の製品のための特定の保管と取扱い情報は、製品データシートの上で示されます。大部分のSelleck製品は、推薦された状況の下で安定です。製品は、推薦された保管温度と異なる温度で、時々出荷されます。長期の保管のために必要とされてそれと異なる温度で、多くの製品は、短期もので安定です。品質を維持するが、夜通しの積荷のために最も経済的な貯蔵状況を用いてあなたの送料を保存する状況の下に、製品が出荷されることを、我々は確実とします。製品の受領と同時に、製品データシートの上で貯蔵推薦に従ってください。